GGC Medicines: Medicines Update

Medicines Update

GGC Medicines Update is a series of blogs with important medicines related messages relevant to all healthcare professionals across GGC.

Subscribe to our blog via email:ggc.medicines.update@nhs.scot
Follow us on Twitter

Please note, Medicines Update blogs are correct at the time of publication.

Medicines Update blogs remain on the website for 4 years. If you would like a copy of a blog published more than 4 years ago, please contact ggc.medicines.update@nhs.scot.

Click here for a promotional poster on Medicines Update and here for an animation on the Communications subcommittee of ADTC responsible for the development of Medicines Update.

If you would like to contribute to Medicines Update, click here for further information and here for a guide to blog writing. When you email the committee to discuss writing a blog, you will be sent a checklist to complete prior to submitting the blog for review.

Showing 221 - 230 of 268 records.

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Previous page | Next page

Primary Care Prescribing Guidance – Wound Care Protectors for lower limbs

Posted: Wednesday, January 19, 2022

Category - Medicines Update

Seal-Tight ™ wound care protectors are included in the NHSGGC Wound formulary for use on chronic lower limb wounds
They are not to be prescribed for patients who can remove compression hosiery or wound dressings and reapply independently after bathing or patients with fracture casts.

Provision of contraception during COVID-19: Update Jan 2022

Posted: Wednesday, January 19, 2022

Category - Medicines Update

Hospital Medicines added to GP practice prescription record

Posted: Wednesday, January 12, 2022

Category - Medicines Update

Adding “outside” medicines (those prescribed and supplied outside the practice) to patient prescriptions will result in:

Safer prescribing: prescription record is complete allowing GP practice clinical decision support to flag drug interactions
Increased patient safety: these medicines appear in the Emergency Care Summary (ECS)
Improved medicines reconciliation: due to more complete record of prescribing in ECS

Guideline News December 2021

Posted: Tuesday, January 11, 2022

Category - Medicines Update

Guideline News December 2021

Key Medicine Shortages – December 2021

Posted: Wednesday, January 5, 2022

Category - Medicines Update

Key Medicine Shortages for December 2021

MHRA Drug Safety Update December 2021

Posted: Wednesday, December 22, 2021

Category - Medicines Update

MHRA Drug Safety Update for December 2021

COVID-19 Treatment Update - Dec 2021

Posted: Friday, December 10, 2021

Category - Medicines Update

Ronapreve® is now indicated in two distinct patient populations:

Group 1: Patients admitted unwell with COVID-19 who are negative for baseline serum anti-spike (anti-S) antibodies against SARS-CoV-2.

Group 2: Patients with early hospital onset COVID-19 who are at high risk of progression to severe COVID-19 or in whom COVID-19 infection presents a material risk of destabilising a pre-existing condition or illness or compromising recovery from surgery or other hospital procedure.